| Autor: |
Pisani AR; Nuclear Medicine Unit, Interdisciplinary Department of Medicine (DIM), University of Bari 'Aldo Moro', 70124 Bari, Italy. ferrari_cristina@inwind.it., Rubini D, Altini C, Lucarelli N, Gaudiano A, Ferrari C, Rubini G |
| Jazyk: |
angličtina |
| Zdroj: |
Hellenic journal of nuclear medicine [Hell J Nucl Med] 2024 Jan-Apr; Vol. 27 (1), pp. 58-63. Date of Electronic Publication: 2024 Apr 18. |
| DOI: |
10.1967/s002449912705 |
| Abstrakt: |
Cerebrospinal fluid (CSF) shunting is an established long-term treatment option for hydrocephalus, and is one of the most commonly performed neurosurgical procedures in western countries.Despite advances in CSF shunt design and management, its failure rates remain high and is most commonly due to obstruction and infection.Cerebrospinal fluidshunt failure diagnosis should be prompt and accurate in establishing timely if its revision is appropriate. Radionuclide shuntography with technetium-99m-diethylenetriaminepetaacetic acid ( 99m Tc-DTPA) is a useful technique for evaluation CSF shunts and management of patients presenting with shunt-related problems, in particular it can avoid unnecessary replacement interventions. Although its execution and interpretation require specific skills, we suggest its execution for the evaluation of device's patency. We here describe the radionuclide shuntography performed with recent hybrid multimodal technologies, with a procedure customized to a complicated patient with hydrocefalus and neoplastic disease. We suggest considering radionuclide shuntography in association with conventional imaging and strongly recommend the additional performance of single photon emission computed tomography/computed tomography (SPECT/CT) because it also provides valuable information to complete the interpretation of planar images. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
